(Q34309474)

English

A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).

scientific article

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

0 references

A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). (English)

1 reference

Europe PubMed Central

1 August 2017

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) (English)

0 references

post-traumatic stress disorder

0 references

author name string

Peter Oehen

1

1 reference

Europe PubMed Central

1 August 2017

Rafael Traber

2

1 reference

Europe PubMed Central

1 August 2017

Verena Widmer

3

1 reference

Europe PubMed Central

1 August 2017

Ulrich Schnyder

4

1 reference

Europe PubMed Central

1 August 2017

language of work or name

0 references

publication date

31 October 2012

1 reference

Europe PubMed Central

1 August 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

1 August 2017

27

1 reference

Europe PubMed Central

1 August 2017

1

1 reference

Europe PubMed Central

1 August 2017

40-52

1 reference

Europe PubMed Central

1 August 2017

Effects of MDMA on sociability and neural response to social threat and social reward

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

The early history of "Ecstasy"

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

The human dimension: how the prefrontal cortex modulates the subcortical fear response

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Traumatic events and posttraumatic stress disorder in an urban population of young adults

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Social bonds and posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

The validation of a self-report measure of posttraumatic stress disorder: The Posttraumatic Diagnostic Scale

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Toward a Psychobiology of Posttraumatic Self-Dysregulation: Reexperiencing, Hyperarousal, Dissociation, and Emotional Numbing

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

A method of conducting therapeutic sessions with MDMA.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Prevalence of exposure to potentially traumatic events and PTSD. The Zurich Cohort Study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Substance use disorders in patients with posttraumatic stress disorder: a review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Posttraumatic stress disorder in the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Gender differences in the subjective effects of MDMA.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

The long-term costs of traumatic stress: intertwined physical and psychological consequences

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

A sensorimotor approach to the treatment of trauma and dissociation

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

A meta-analysis of the association between posttraumatic stress disorder and suicidality: the role of comorbid depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Traumatic events and post-traumatic stress disorder in the community: prevalence, risk factors and comorbidity

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Clinician-administered PTSD scale: a review of the first ten years of research

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population.

1 reference

https://api.crossref.org/works/10.1177%2F0269881112464827

21 January 2018

Identifiers

10.1177/0269881112464827

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34309474&oldid=1980621204"